peripheral nervous system disease: A disease involving the peripheral nervous system.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
112 |
4. Check minimum number of eventsNone |
112 |
5. Include endpointsNone |
112 |
6. Filter based on genotype QC (FinnGen only) |
103 |
Control definitions (FinnGen only)
- Control exclude
- G6_NERPLEX
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Phantom limb syndrome
based on the number of shared cases.
Similar with more cases:
- Nerve, nerve root and plexus disorders
- Neurological diseases
- Neurological diseases, wide definition
- Any operation in hilmo
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 726 | 302 | 414 |
| Only index persons | 586 | 241 | 345 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.01 | 0.01 | 0.01 |
| Only index persons | 0.01 | 0.01 | 0.01 |
| Median age at first event (years) | |||
| Whole population | 56.02 | 56.33 | 55.54 |
| Only index persons | 53.45 | 53.67 | 53.29 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 103 | 48 | 55 |
| Unadjusted period prevalence (%) | 0.02 | 0.02 | 0.03 |
| Median age at first event (years) | 55.90 | 51.19 | 60.00 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 104
- Matched controls
- 1040
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
G54.6
ICD-10 Finland
Phantom limb syndrome with pain
+∞
139.3
100
*
N03AX16
ATC
[U] pregabalin
21.7
58.1
73
102
N03AX12
ATC
[U] gabapentin; oral
13.5
40.6
55
80
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
11.0
30.0
41
58
NGQ20
NOMESCO Finland
Amputation of lower leg
189.1
28.2
28
*
N02AA05
ATC
oxycodone; systemic
8.7
27.6
53
111
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
9.2
21.8
32
48
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
35.8
21.4
27
10
L28
ICPC
Limited function/disability (L)
6.9
20.5
45
104
N06AA09
ATC
amitriptyline; systemic
8.8
17.9
26
38
N06AX21
ATC
duloxetine; oral
7.5
17.7
31
56
N02AX02
ATC
tramadol; systemic, rectal
6.2
17.4
75
307
NFQ20
NOMESCO Finland
Amputation of femur
107.7
17.2
18
*
SPAT1229
SPAT
Assessment of need for aid
8.6
17.0
25
37
J01FF01
ATC
clindamycin; systemic
5.4
16.5
53
168
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
7.7
16.0
26
43
NHQ30
NOMESCO Finland
Amputation of foot, transmetatarsal
187.0
15.9
16
*
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
15.3
15.7
26
22
NHQ40
NOMESCO Finland
Amputation of toe
38.2
15.4
19
6
S97
ICPC
Chronic ulcer skin
7.5
14.6
24
40
A46
ICD-10 Finland
Erysipelas
5.6
14.6
36
90
J01MA02
ATC
ciprofloxacin; systemic
4.7
13.4
66
282
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
14.3
13.1
22
19
SPAT1148
SPAT
Treatment of chronic ulcer or burn
5.7
12.9
29
66
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
5.5
12.9
31
75
WX213
NOMESCO Finland
Lower leg blockade
+∞
12.8
12
*
N06AX16
ATC
venlafaxine; oral
5.5
12.5
30
72
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
4.9
12.4
36
102
TPH07
NOMESCO Finland
Cathetrisation of artery
5.6
12.0
27
61
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
34.6
12.0
15
5
ZXE20
NOMESCO Finland
More than three and less than five hours
5.1
11.9
31
80
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
6.8
11.5
20
35
G56.0
ICD-10 Finland
Carpal tunnel syndrome
12.1
11.1
20
20
S18
ICPC
Laceration/cut
4.0
10.7
69
341
PF1AT
NOMESCO Finland
Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)
121.8
10.6
11
*
QDG20
NOMESCO Finland
Operation for chronic ulcer or fistula of skin of lower limb
121.8
10.6
11
*
Z89.5
ICD-10 Finland
Acquired absence of leg at or below knee
121.8
10.6
11
*
J01MA12
ATC
levofloxacin; systemic
4.2
10.6
39
131
TPH04
NOMESCO Finland
Cathetrisation of vein
4.2
10.6
39
131
L17
ICPC
Foot/toe symptom/complaint
3.9
10.6
50
200
PD4AC
NOMESCO Finland
Arterigography of lower extremity with X-ray
26.6
10.6
14
6
N03AE01
ATC
clonazepam; systemic
10.5
10.4
20
23
WX212
NOMESCO Finland
Femoral plexus blockade
19.2
10.2
15
9
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
4.8
10.0
27
71
A28
ICPC
Limited function/disability NOS
4.2
9.8
33
103
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
4.6
9.8
28
77
N03AX09
ATC
lamotrigine; oral
12.4
9.7
17
16
N02BF01
ATC
gabapentin; oral
5.5
9.6
21
46
A10AE04
ATC
insulin glargine; parenteral
5.1
9.5
23
55
R52.2
ICD-10 Finland
Other chronic pain
17.7
9.3
14
9
C03CA01
ATC
furosemide; systemic
3.5
9.2
51
222
G54.0
ICD-10 Finland
Brachial plexus disorders
40.5
9.2
11
*
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
26.8
9.1
12
5
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
5.2
9.1
21
48
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.8
8.9
36
127
ZXD05
NOMESCO Finland
Urgent procedure
3.5
8.8
48
206
ZZA00
NOMESCO Finland
Split skin graft
18.3
8.8
13
8
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
4.9
8.8
22
54
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
4.6
8.7
24
64
X58
ICD-10 Finland
Exposure to other specified factors
4.3
8.7
27
79
M79.6
ICD-10 Finland
Pain in limb
3.4
8.5
62
317
E11.5
ICD-10 Finland
Type 2 diabetes mellitus, with peripheral circulatory complications
16.3
8.5
13
9
SPAT1301
SPAT
No procedures
3.4
8.4
46
197
X59
ICD-10 Finland
Exposure to unspecified factor
3.7
8.2
33
116
N05CD07
ATC
temazepam; oral
4.7
8.1
21
53
WX725
NOMESCO Finland
Noninvasive ventilation
9.2
7.9
16
20
ZXA00
NOMESCO Finland
Right side
3.4
7.9
40
162
F32.9
ICD-10 Finland
Depressive episode, unspecified
4.9
7.9
19
45
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
7.5
7.8
18
28
Z01.8
ICD-10 Finland
Other specified special examinations
3.6
7.8
34
125
N06AX11
ATC
mirtazapine; oral
3.2
7.7
50
235
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
4.3
7.7
23
65
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
7.6
7.5
17
26
SPAT1262
SPAT
Handing over of treatment supplies
3.7
7.4
29
99
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
17.4
7.4
11
7
ACC51
NOMESCO Finland
Release of median nerve
+∞
7.4
7
*
PD4BC
NOMESCO Finland
Extensive arterigography of lower extremity with X-ray
21.9
7.3
10
5
PE1AT
NOMESCO Finland
Femoral artery PTA
21.9
7.3
10
5
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
7.0
7.1
17
28
A06AD11
ATC
lactulose; oral
3.9
7.1
24
74
N05CF01
ATC
zopiclone; oral
3.1
7.0
45
208
WX306
NOMESCO Finland
Lumbar epidural anesthesy
6.8
7.0
17
29
A01
ICPC
Pain general/multiple sites
4.3
6.9
20
55
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
3.1
6.9
38
161
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
24.4
6.8
9
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.7
6.7
25
82
SPAT1149
SPAT
Suture or treatment of traumatic wound
4.0
6.7
22
66
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
3.6
6.7
26
88
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
5.8
6.6
18
36
B01AC04
ATC
clopidogrel; oral
3.4
6.5
29
107
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
74.2
6.5
7
*
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
74.2
6.5
7
*
Z3231
NOMESCO Finland
Registered nurse
3.0
6.4
41
187
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.6
6.4
24
79
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.9
6.3
65
382
NGQ48
NOMESCO Finland
Revision of exarticulation or amputation stump of knee or lower leg
+∞
6.3
6
*
NFQ48
NOMESCO Finland
Revision of exarticulation or amputation stump of hip or femur
+∞
6.3
6
*
Y84
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
+∞
6.3
6
*
T87.6
ICD-10 Finland
Other and unspecified complications of amputation stump
+∞
6.3
6
*
ZXE30
NOMESCO Finland
More than five and less than seven hours
6.8
6.3
15
25
A10AB05
ATC
insulin aspart; parenteral
4.4
6.3
17
44
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
4.2
6.2
18
49
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
5.8
6.2
17
34
ZXE10
NOMESCO Finland
More than one and less than three hours
2.8
6.2
48
243
WZC00
NOMESCO Finland
Treatment plan or consultation
2.8
6.2
49
251
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
4.5
6.2
16
40
205
Kela drug reimbursment
Chronic hypertension
3.0
6.2
37
163
N02BF02
ATC
pregabalin; oral
6.1
6.1
16
30
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
6.1
6.1
16
30
Z3226
NOMESCO Finland
Physiotherapist
3.3
6.1
28
105
WX704
NOMESCO Finland
Intubation
7.2
6.1
14
22
M75.1
ICD-10 Finland
Rotator cuff syndrome
2.9
6.1
37
164
C10AA01
ATC
simvastatin; oral
2.8
6.0
54
293
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
11
7
17.35
7.41
12.6
15.1
12.51
11.51
mg/l
—
11
7
32
121
3.38
6.97
1.9
1.6
—
—
—
0
0
69
417
2.95
6.38
5.3
2.9
—
—
estimate
—
0
0
30
116
3.23
6.25
2.0
1.7
—
—
—
0
0
28
106
3.25
6.02
11.4
14.2
5.16
5.11
kpa
0.11
28
101
12
16
8.32
5.82
2.5
1.3
—
—
—
0
0
20
64
3.63
5.54
1.5
1.6
—
—
—
0
0
36
165
2.81
5.49
2.6
1.7
—
—
—
0
0
42
209
2.69
5.46
4.1
2.0
3.44
3.00
mg/l
0.37
37
179
63
387
2.59
5.26
2.5
2.0
95.58
94.43
pmol/l
0.07
33
189
33
154
2.67
4.79
4.8
3.9
0.78
0.82
mmol/l
1.07
33
148
13
28
5.15
4.55
3.8
1.5
—
—
—
0
0
21
79
3.08
4.49
2.8
2.9
0.22
0.22
g/l
0.10
21
72
48
282
2.30
4.15
3.7
2.2
106.25
285.65
u/l
1.94
48
272
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
12
28
4.70
3.96
3.5
2.4
0.25
0.37
iu/ml
—
7
14
69
483
2.27
3.79
9.7
7.3
9.96
12.17
umol/l
1.57
69
463
39
222
2.21
3.53
4.6
2.4
—
—
—
0
0
48
306
2.06
3.18
6.6
4.0
21.88
9.24
mg/mmol
0.87
36
206
14
51
3.02
3.13
1.3
1.0
18.12
186.13
u/ml
—
5
22
46
305
1.91
2.61
4.6
3.1
5691.96
1135.02
ng/l
0.75
39
256
18
84
2.38
2.52
7.8
9.2
1.07
1.39
mmol/l
1.27
18
84
25
136
2.10
2.45
10.8
8.5
105.36
103.98
mmol/l
1.21
25
136
5
8
6.49
2.40
1.4
1.3
—
—
—
0
0
6
13
4.82
2.30
1.7
1.6
—
—
—
0
0
13
56
2.51
2.15
11.1
8.8
25.15
25.16
mmol/l
0.00
13
56
40
268
1.80
2.12
2.4
1.6
15.45
20.76
nmol/l
2.52
33
219
15
71
2.30
2.04
1.5
1.3
—
—
—
0
0
31
194
1.85
2.03
8.2
3.5
1.02
1.02
kg/l
0.56
26
121
66
517
1.76
1.99
14.7
9.5
4.15
4.07
e9/l
0.12
60
434
7
22
3.33
1.91
1.9
1.5
—
—
—
0
0
29
181
1.84
1.91
6.7
3.6
325.83
420.30
ng/l
0.12
23
143
8
28
3.01
1.90
1.6
1.5
—
—
—
0
0
6
17
3.68
1.86
2.0
1.1
—
—
—
0
0
7
23
3.19
1.83
1.6
1.3
0.19
0.22
g/l
—
7
23
48
352
1.68
1.79
6.9
3.7
33.87
50.14
ng/l
0.60
37
263
8
31
2.71
1.70
5.8
3.3
—
—
—
0
0
7
25
2.93
1.68
1.4
1.8
—
—
—
0
0
21
123
1.89
1.67
1.4
1.3
19.35
15.76
u/ml
—
8
45
5
14
3.69
1.63
1.0
1.1
—
—
—
0
0
5
15
3.45
1.54
1.6
1.3
—
—
—
0
0
6
21
2.97
1.53
1.5
1.4
—
—
—
0
0
7
29
2.51
1.42
1.9
1.4
—
—
—
0
0
7
29
2.51
1.42
1.7
1.1
—
—
—
0
0
6
23
2.70
1.39
1.7
1.4
1.18
1.14
g/l
—
6
23
28
190
1.65
1.35
1.6
1.2
1.37
0.81
u/ml
—
6
54
5
18
2.86
1.30
2.2
1.5
—
—
—
0
0
5
18
2.86
1.30
2.2
1.4
—
—
—
0
0
5
19
2.71
1.23
1.2
1.3
—
14.39
—
0
7
95
877
1.96
1.22
49.6
15.6
26.81
25.15
mg/l
0.22
87
709
11
58
2.00
1.17
10.8
4.5
23.71
24.13
mmol/l
0.19
11
58
5
20
2.57
1.16
1.2
1.6
—
—
—
0
0
5
20
2.57
1.16
1.2
1.7
—
—
—
0
0
15
92
1.74
1.04
1.5
2.1
1.91
1.61
%
0.72
15
75
23
159
1.57
1.03
4.7
2.8
0.39
0.86
e6/l
1.10
13
78
81
728
1.51
0.94
49.6
20.4
14.20
13.64
%
2.67
81
722
16
104
1.64
0.91
12.3
3.0
—
—
—
0
0
95
892
1.75
0.87
52.7
19.5
139.14
139.75
mmol/l
1.18
95
876
95
892
1.75
0.87
52.9
19.7
4.01
3.97
mmol/l
0.74
95
874
5
23
2.23
0.77
2.2
1.9
—
—
—
0
0
5
24
2.14
0.75
1.2
1.8
—
—
—
0
0
7
119
0.56
0.73
1.9
1.5
—
—
—
0
0
5
27
1.89
0.69
1.0
1.3
—
—
—
0
0
59
518
1.32
0.67
3.3
2.9
—
—
—
0
0
8
49
1.68
0.64
1.5
1.2
—
—
—
0
0
11
72
1.59
0.62
7.3
3.0
55.83
61.20
ml/min/173m2
—
6
35
0
20
0.00
0.61
0.0
1.5
—
—
—
0
0
6
36
1.71
0.58
2.0
1.4
4.97
3.28
mg/l
—
6
29
6
36
1.71
0.58
2.8
1.8
—
—
—
0
0
39
329
1.30
0.57
8.5
3.0
—
—
—
0
0
18
141
1.33
0.44
1.9
1.2
166.57
26.00
iu/ml
—
6
47
8
56
1.46
0.44
1.6
1.4
—
—
—
0
0
5
31
1.64
0.43
2.0
2.2
—
—
—
0
0
19
151
1.32
0.42
4.6
3.0
0.13
1.73
e6/l
—
9
71
0
15
0.00
0.41
0.0
1.2
—
1.33
—
0
6
54
490
1.21
0.39
7.5
3.4
0.00
14.25
estimate
0.50
11
114
54
492
1.20
0.37
7.7
3.4
0.00
0.00
estimate
-0.00
11
104
77
726
1.23
0.37
51.3
19.9
330.62
332.71
g/l
1.04
77
726
30
263
1.20
0.30
6.1
5.0
20.87
20.55
%
0.04
12
139
9
73
1.25
0.26
2.3
2.1
—
—
—
0
0
30
268
1.17
0.24
8.4
3.0
0.27
0.42
e6/l
0.58
23
189
5
37
1.37
0.24
2.2
2.1
—
—
—
0
0
11
88
1.28
0.23
4.7
2.3
13.13
12.89
nmol/l
0.04
11
79
52
486
1.14
0.23
7.7
3.4
0.00
0.00
estimate
-0.00
11
109
31
280
1.15
0.22
8.7
3.4
0.00
0.02
estimate
—
8
102
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
2.3
—
19.66
—
0
5
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
0
12
0.00
0.21
0.0
1.7
—
—
—
0
0
95
929
1.26
0.21
54.7
20.7
84.61
79.34
umol/l
0.46
95
923
0
13
0.00
0.21
0.0
1.2
—
116.00
—
0
13
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
83
853
0.87
0.17
39.1
15.9
79.99
80.59
ml/min/173m2
0.09
75
791
18
203
0.86
0.17
3.0
3.4
0.43
0.76
ug/l
3.38
11
140
12
140
0.84
0.16
1.8
1.6
—
—
—
0
0
8
72
1.12
0.16
12.9
3.3
1.22
1.22
mmol/l
—
8
62
9
82
1.11
0.15
1.3
2.4
2.89
6.12
ug/l
—
9
70
14
122
1.17
0.14
4.9
4.7
32.13
32.13
%
—
8
76
5
45
1.12
0.10
1.0
1.1
—
—
—
0
0
6
56
1.08
0.09
4.8
2.3
0.67
1.06
%
—
6
56
9
84
1.08
0.07
1.8
1.9
3.96
3.33
ratio
—
9
66
9
85
1.06
0.07
2.7
2.1
—
—
—
0
0
26
267
0.97
0.01
6.8
2.9
0.00
0.00
estimate
—
10
82
37
368
1.01
0.00
8.6
3.3
0.00
0.03
estimate
—
10
90
10
103
0.97
0.00
4.3
6.7
—
—
—
0
0
6
61
0.98
-0.00
1.3
1.8
3.58
3.52
mmol/l
—
6
44
96
954
1.08
-0.00
63.7
23.3
91.27
91.36
fl
0.07
96
943
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.9
—
12.88
—
0
8
0
6
0.00
-0.00
0.0
1.0
—
2112.17
—
0
6
0
5
0.00
-0.00
0.0
2.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.7
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
96
954
1.08
-0.00
64.2
23.5
129.07
135.83
g/l
3.71
96
943
0
5
0.00
-0.00
0.0
1.4
—
122.00
—
0
5
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.4
—
61.91
—
0
9
96
954
1.08
-0.00
64.8
24.0
39.17
40.60
%
2.39
96
943
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.7
—
972.71
—
0
7
0
6
0.00
-0.00
0.0
2.7
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint G6_PHANTOM and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| G6_PHANTOM | 2.961 [1.92, 4.57] | < 0.001 |
| Birth year | 0.991 [0.98, 1.0] | 0.056 |
During the follow-up period (1.1.1998 — 31.12.2019), 90 out of 261 females with G6_PHANTOM died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| G6_PHANTOM | 2.061 [1.55, 2.74] | < 0.001 |
| Birth year | 0.985 [0.98, 0.99] | 0.002 |
During the follow-up period (1.1.1998 — 31.12.2019), 119 out of 361 males with G6_PHANTOM died.
Mortality risk
Mortality risk for people of age
years, who have G6_PHANTOM.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.282% | 0.327% |
| 5 | 1.348% | 2.281% |
| 10 | 3.262% | 5.933% |
| 15 | 6.514% | 10.869% |
| 20 | 12.15% | 17.885% |
Relationships between endpoints
↥Index endpoint: G6_PHANTOM – Phantom limb syndrome
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data